SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 144 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,004 | 0.0% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $2,004 | +34.5% | 40,000 | 0.0% | 0.00% | +33.3% |
| Q4 2023 | $1,490 | +267.9% | 40,000 | +131.9% | 0.00% | +200.0% |
| Q3 2023 | $405 | -7.1% | 17,250 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $436 | -0.9% | 17,250 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $440 | +4.5% | 17,250 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $421 | -99.9% | 17,250 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $473,000 | +7.5% | 17,250 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $440,000 | -57.2% | 17,250 | 0.0% | 0.00% | -66.7% |
| Q1 2022 | $1,029,000 | +8.0% | 17,250 | +10.2% | 0.00% | +50.0% |
| Q4 2021 | $953,000 | -0.3% | 15,650 | +2.6% | 0.00% | -33.3% |
| Q3 2021 | $956,000 | -20.9% | 15,250 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $1,209,000 | +15.8% | 15,250 | 0.0% | 0.00% | +33.3% |
| Q1 2021 | $1,044,000 | -5.9% | 15,250 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $1,109,000 | – | 15,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $429,009,000 | 24.30% |
| Consonance Capital Management LP | 1,201,399 | $88,387,000 | 9.42% |
| Boxer Capital, LLC | 2,075,905 | $152,724,000 | 5.18% |
| Perceptive Advisors | 4,849,912 | $356,808,000 | 4.51% |
| Orbimed Advisors | 6,186,307 | $455,127,000 | 4.26% |
| Samsara BioCapital, LLC | 169,852 | $12,496,000 | 2.30% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,262,075 | $92,851,000 | 1.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $41,094,000 | 0.86% |
| SPHERA FUNDS MANAGEMENT LTD. | 137,672 | $10,129,000 | 0.78% |
| Affinity Asset Advisors, LLC | 27,000 | $1,986,000 | 0.67% |